Finding drugs against CD133+ glioma subpopulations.
Ichiro
I
Nakano
E Antonio
EA
Chiocca
D000071916:AC133 Antigen; D015703:Antigens, CD / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D000068579:Celecoxib; D003131:Combined Modality Therapy; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D005910:Glioma / Q000188:drug therapy* / Q000378:metabolism*; D006023:Glycoproteins / Q000378:metabolism*; D006801:Humans; D014411:Neoplastic Stem Cells / Q000473:pathology; D010455:Peptides / Q000378:metabolism*; D057285:Precision Medicine; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D000071916:AC133 Antigen; D015703:Antigens, CD; D000970:Antineoplastic Agents; D052246:Cyclooxygenase 2 Inhibitors; D006023:Glycoproteins; C000606023:PROM1 protein, human; D010455:Peptides; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib